Posters

Search Title by author or title

Efficacy of 1% carboxymethylcellulose sodium for treating dry eye syndrome in perioperative period of cataract phacoemulsification: own results

Poster Details

First Author: K.Jadczyk Sorek POLAND

Co Author(s):    P. Smoliński   E. Mrukwa-Kominek                 

Abstract Details

Purpose:

The aim of the study was to evaluate the efficiacy of 1% carboxymethylcellulose sodium in the assessment of dry eye syndrome and tear film stabilization in the perioperative period in people undergoing cataract phacoemulsification.

Setting:

Professor K. Gibiński University Clinical Center, Medical University of Silesia, Katowice, Poland

Methods:

Patients were randomized into 2 groups: study group – patients who took drops Droptiva plus 3 times daily from qualification visit up to 2 weeks after cataract surgery; control group consists of patients who did not take artificial tear preparations. The use of antiglaucoma drops was an exclusion criterium. During 4 visits in the -14, 0, 1, 14 days scheme, where 0 corresponded to the day of catarct surgery, there were assessed: corneal staining (according to Oxford scale), ocular conjunctival irritation (according to McMonnies scale), tear breakup time (TBUT) and Ocular Surface Disease Index (OSDI) questionnaire.

Results:

At the first visit, the average OSDI value was 41,28 and 35,53 points and fell by 17,3 and 13,78 points at the last visit for the study and control group respectively. The TBUT in control points was: 4,1s; 5,5s; 4,8s; 7,5s and 5,3s; 4,9s; 3,2s; 6,5s respectively for the study and control group. At the first visit in the study group none of patients achieved correct corneal staining and in control group this affected 20% of patients. On the phacoemulsification day 71% of patients in the study group and 20% in the control group were rated as a grade 0.

Conclusions:

Based on obtained results treatment with CMC 1% is effective in preparing the eye surface for catarct surgery and can provide improvement in tear film stability after cataract phacoemulsification.

Financial Disclosure:

None

Back to Poster listing